50,035 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Purchased by Graypoint LLC

Graypoint LLC bought a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 50,035 shares of the company’s stock, valued at approximately $1,161,000.

Several other hedge funds have also recently bought and sold shares of the company. Harbor Capital Advisors Inc. lifted its stake in Option Care Health by 2.7% during the 4th quarter. Harbor Capital Advisors Inc. now owns 213,155 shares of the company’s stock worth $4,945,000 after acquiring an additional 5,595 shares in the last quarter. Nordea Investment Management AB lifted its stake in Option Care Health by 6.0% during the 4th quarter. Nordea Investment Management AB now owns 94,641 shares of the company’s stock worth $2,165,000 after acquiring an additional 5,365 shares in the last quarter. Central Pacific Bank Trust Division lifted its stake in Option Care Health by 6.9% during the 4th quarter. Central Pacific Bank Trust Division now owns 10,079 shares of the company’s stock worth $234,000 after acquiring an additional 650 shares in the last quarter. TD Private Client Wealth LLC lifted its stake in Option Care Health by 21.4% during the 3rd quarter. TD Private Client Wealth LLC now owns 5,723 shares of the company’s stock worth $179,000 after acquiring an additional 1,007 shares in the last quarter. Finally, Teachers Retirement System of The State of Kentucky lifted its stake in Option Care Health by 4.1% during the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 390,921 shares of the company’s stock worth $12,236,000 after acquiring an additional 15,357 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have issued reports on OPCH. The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and reduced their price target for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Barrington Research reduced their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research report on Friday. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and reduced their price target for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. Finally, Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and reduced their price target for the company from $43.00 to $29.00 in a research report on Wednesday, October 30th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $29.14.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $23.99 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.63. The firm has a market capitalization of $4.08 billion, a PE ratio of 20.16, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31. The stock’s 50-day simple moving average is $23.10 and its 200-day simple moving average is $27.70.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were purchased at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the purchase, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This represents a 15.18 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.